Literature DB >> 3662286

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents.

D J Gordon1, B M Rifkind.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3662286     DOI: 10.7326/0003-4819-107-5-759

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  Natural products as a resource for new drugs.

Authors:  A M Clark
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

Review 2.  Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative.

Authors:  E E Slater; J S MacDonald
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of pravastatin.

Authors:  J A Quion; P H Jones
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.